Advagene Biopharma Co., Ltd. (TPEX:6709)
28.75
-0.75 (-2.54%)
Mar 24, 2026, 1:59 PM CST
31.28% (1Y)
| Market Cap | 1.71B +43.6% |
| Revenue (ttm) | n/a |
| Net Income | -68.29M |
| EPS | -1.15 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 106,347 |
| Average Volume | 82,226 |
| Open | 30.00 |
| Previous Close | 29.50 |
| Day's Range | 27.90 - 30.00 |
| 52-Week Range | 15.75 - 41.00 |
| Beta | 0.77 |
| RSI | 36.25 |
| Earnings Date | Mar 27, 2026 |